Introduction
============

Spinal cord injury (SCI) results in limited motor function recovery under the chronic phase, mainly because of the poor regenerative capability of adult mammalian central nervous system (CNS) ([@B16]). SCI is composed of three phases, acute, secondary and chronic, and its outcomes are influenced by the secondary phase ([@B36]). The secondary phase is characterized by inflammation-triggered events as follows: edema, apoptosis of cells including neurons and oligodendrocytes, demyelination, astrocytic scar formation and so on ([@B53]). Under the secondary phase of SCI, gradual functional recovery is observed in several animals including humans, the extent of which is inversely related to the intensity of primary damage ([@B5]). It is thus logical to postulate that reduction of secondary damage waves by controlling inflammation-triggered events may improve the functional recovery after SCI.

p38 is one of mitogen-activated protein kinases (MAPKs) which transduces a variety of extracellular signals to the transcriptional machinery. By using genetically engineered mice, it has been demonstrated that p38 participates at least in inflammatory responses and cell fate decision including apoptosis ([@B33]; [@B48]; [@B18]; [@B38]). Among four mammalian isoforms of p38 (α, β, γ, and δ), p38α is expressed ubiquitously in adult tissues and functions as a central player of p38 isoforms ([@B20]). Although *p38*α *gene* (*MAPK14*) deficiency results in lethality in homozygous embryonic mice, the p38α^+/-^ mouse is a useful tool for studying the *in vivo* role of p38α in certain disease models ([@B46]; [@B45]; [@B24]). In particular, p38α^+/-^ mice show an outstanding resistance to neurodegenerative diseases such as epileptic seizure and experimental autoimmune encephalomyelitis (EAE, an animal model of multiple sclerosis associated with demyelination in the SC) ([@B28], [@B27]). In contrast, the deterioration of EAE was observed in transgenic mice expressing a constitutive active form of MKK6, a p38-specific activator ([@B31]). Furthermore, self-renewal activity and neural differentiation capacity of neural stem cells (NSCs) in the hippocampus of p38α^+/-^ mice are higher than those of WT mice ([@B51]). These previous findings tempt us to think that inhibition of p38α may be beneficial to the functional recovery after SCI. In fact, it has been demonstrated that a p38α inhibitor, SB203580 could reduce the damage of hindlimb function after SCI ([@B15]). In contrast, another group showed that SB203580 failed to improve functional outcome after SCI ([@B44]). Those reports are fully controversial though employing a similar SCI protocol and a same administration procedure. Therefore, whether p38α is recognized as a potential therapeutic target in SCI is still under debate.

Here, we first showed that the hindlimb locomotor behavior was improved in p38α^+/-^ mice compared to WT mice. As the mechanisms underlying the improved signs of SCI in p38α^+/-^ mice, various pathological aspects under the secondary phase of SCI were examined between WT and p38α^+/-^ mice. We finally showed that oral administration of SB239063, a p38α-specific inhibitor might be beneficial to functional recovery after SCI.

Materials and Methods {#s1}
=====================

Animals
-------

All animal procedures conformed to the Japanese regulations for animal care and use, following guideline for Animal Experimentation of the Japanese Association for Laboratory Animal Science, and were approved by the Animal Care and Use Committee of Chiba University. Male mice heterozygous for targeted disruption of the p38α *gene* ([@B46]) were crossed with C57BL6J female mice (Tokyo Experimental Animal Co., Tokyo, Japan) to generate p38α^+/-^ and p38α^+/+^ \[Wild type (WT)\] mice. Genotyping by PCR analysis of tail-derived DNA was performed according to our previous report ([@B45]).

SCI Model
---------

Male WT and p38α^+/-^ mice aged 10--14 weeks were used for each experiment. Mice were deeply anesthetized with isoflurane. Laminectomy was performed at the thoracic levels of T8-10 to expose the spinal cord (SC), taking care not to damage the SC. Mice of the sham-operated group underwent laminectomy alone. Using a micro dissecting forceps, mice of the SCI group underwent right lateral hemisection at T9. Then, the muscle layer and the skin were sutured. After awaking fully from anesthesia, paralysis of the right hindlimb was assessed. The right hindlimb movement was not observed in this SCI model mice at the surgical day (day 0). At day 0, therefore, mice showing the movement of right hindlimb or with paraplegia were excluded from the following assessment and experiments. The urine was squeezed out by manual abdominal pressure on the bladder twice daily until reflex bladder function would be recovered. To determine the effect of a p38α inhibitor on SCI, each mouse received oral administration of SB239063 in acidified 0.5% tragacanth (10 mg/kg per day; Sigma--Aldrich, St. Louis, MO, USA) at 1, 2, and 3 dpi, and the control group received oral administration of vehicles, acidified 0.5% tragacanth.

Behavior Study
--------------

We evaluated the motor function of the SCI-associated paralyzed hindlimbs from 0 to 28 days post-injury (dpi), based on Basso Mouse Scale (BMS) ([@B3]). The BMS is a 9 point scale for assessment of functional recovery of mice's hindlimbs. Mice were forced to walk in an open field, and their right hindlimbs movement was observed for 4 min to score based on BMS.

Tissue Preparation and Histological Analysis
--------------------------------------------

Mice were anesthetized lethally and transcardially perfused with ice-cold phosphate-buffered saline (PBS). SCs including the lesions were carefully dissected out, fixed overnight in 4% paraformaldehyde and subsequently immersed in 30% sucrose for 2 days to cryoprotect the tissues. After embedding into OCT compound, the samples were transversely or sagittally sectioned at a thickness of 20 μm. Sagittal and transverse sections were stained with hematoxylin-eosin (HE) and by a Kluver-Barrera's (KB) method, respectively. The injury-associated leukocyte infiltration area and Luxol Fast Blue (LFB)-staining area in sections stained with HE and by a KB method, respectively, were quantified using Macromax MVC-DU (GOKO, Kanagawa, Japan).

Tracing Study
-------------

For anterograde tracing of axons, a total of 2 μl of 10% Texas Red-conjugated biotinylated dextran amine (Texas Red-BDA; Vector Laboratories, Burlingame, CA, USA) was injected into four sites of sensorimotor cortex in the left side (contralateral to the side of injured SC) at 14 dpi. The scalp was cut and a hole was carefully drilled into the skull, and then Texas Red-BDA was injected into the sensorimotor cortex using a 10 μl Hamilton microsyringe. The scalp was closed with suture. Mice applied with Texas Red-BDA were killed at 28 dpi. Sagittal sections (20 μm thick) from the SCs were observed by a fluorescence microscope (Axio Imager A2, Zeiss, Oberkochen, Germany). Texas Red-BDA-staining area in a visual field was quantified using ImageJ 1.45.

Immunofluorescence Study
------------------------

The freshly cut sagittal sections (20 μm thick) placed on poly-[L]{.smallcaps}-lysine-coated slides were pretreated with 1:10 FcR blocking agent (Miltenyi Biotec, Gladbach, Germany) for 10 min and reacted with various primary antibodies as follows: anti-CNPase (Sigma--Aldrich, St. Louis, MO, USA) to label oligodendrocytes, anti-cleaved caspase-3 (Cell Signaling Tech., Beverly, MA, USA) to label apoptotic cells, Cy3-conjugated anti-glial fibrillary acidic protein (GFAP; Sigma--Aldrich) to label astrocytes, anti-Iba1 (WAKO, Osaka, Japan) to label microglia or macrophages, Cy3-conjugated anti-NG2 (Merck Millipore, Billerica, MA, USA) to label to oligodendrocyte precursors, FITC-conjugated anti-CD45.2 (BioLegend, San Diego, CA, USA) to label leukocytes, biotin-labeled anti-CD3 (Affymetrix, Santa Clara, CA, USA) to label T lymphocytes. After staining with each appropriate fluorescein-conjugated second antibody or streptavidin, 4′, 6-diamidino-2-phenylindole (DAPI) was applied for nuclear staining before the final washing step. The sections were observed by a fluorescence microscope. In case of counting cells immunoreacted with antibodies, 4--5 sections from each SC were randomly selected. Under 200× magnification, two fields within 1 mm centered on the lesion epicenter in the SCI group or the corresponding segment in the sham-operated group were randomly chosen in each section, and fluorescent signal-expressing cells were counted and averaged (/0.1 mm^2^).

Western Blot Array Analysis
---------------------------

Male WT and p38α^+/-^ mice of the sham-operated and SCI groups were anesthetized and sacrificed at 7 dpi. Then, each unilateral SC in the right side including with the injured region was dissected out, and cut with the length of 6 mm from the edge of the rostral lesion to caudal side. The SC sample was homogenized, and centrifuged at 9000 × *g* for 20 min at 4°C. The resulting supernatant was subjected to protein assay. Protein sample (60 μg/mouse) from five mice of each group (WT-sham, WT-SCI, p38α^+/-^-sham, p38α^+/-^-SCI) was mixed (300 μg in each group) and subjected to RayBio^®^ Biotin Label-based Mouse Antibody Array 1 (RayBiotech, Norcross, GA, USA), and changes in expression levels of 308 inflammation-related proteins in the samples were evaluated. The array was performed according to the manufacturer's instructions. Using a densitometer, each signal was normalized to the positive internal controls included in the array membrane and expressed as induction ratio of the sham-operated value.

Statistical Analysis
--------------------

All analyses were conducted through GraphPad Prism Version 6 (GraphPad Software, San Diego, CA, USA). Statistical significance was determined by Mann--Whitney *U* test, Student's *t*-test or analysis of variance (ANOVA) followed by Tukey's test, and *P*-value of \< 0.05 were considered to be significant.

Results and Discussion
======================

Recovery of Hindlimb Locomotor Behavior Related to Histopathological Findings in SC after SCI between p38α^+/-^ and WT Mice
---------------------------------------------------------------------------------------------------------------------------

We first addressed to whether a single copy disruption of *p38*α *gene* might affect functional recovery of hindlimb after lateral hemisection employed as SCI model in this study. Although such a laceration injury of SC is not typically seen clinically, a hemisection model is suitable to investigate the pathophysiological elements inhibiting or promoting axonal regeneration across or around the laceration injury as well as the resulting functional impairment and potential recovery ([@B34]). As shown in **Figure [1](#F1){ref-type="fig"}**, p38α^+/-^ mice showed significantly less severe neurological function of paralyzed SCI-associated right hindlimbs at 7 dpi, and then the more improved locomotor function in p38α^+/-^ mice than in WT mice remained until 28 dpi. Therefore, a single copy disruption of *p38*α *gene* suppressed the functional disturbance in the hemisection model of SCI.

![**Time course of hindlimb locomotor behavior after spinal cord injury (SCI).** Wild type (WT) and p38α^+/-^ mice with SCI were observed daily until 28 dpi, and scored based on BMS. Data are shown as mean ± SEM (*n* = 5). The difference between WT (filled squares) and p38α^+/-^ (open circles) mice was statistically significant (^∗^*P* \< 0.05) as determined by Mann--Whitney *U* test for unpaired values at each time point.](fphar-08-00072-g001){#F1}

Then, histopathological changes such as leukocytic infiltration-associated lesion area, myelinated area and axonal regeneration between the two genotypes were examined after SCI (**Figure [2](#F2){ref-type="fig"}**). We calculated the leucocytic infiltration area using sagittal sections stained with HE at 1, 2, and 4 wpi (**Figures [2A,C](#F2){ref-type="fig"}**). There was no significant difference in the size of leukocyte infiltration-associated lesion between the two genotypes at 1 wpi. The SCI-induced lesion was reduced in a time-dependent manner in the two genotypes at 2 and 4 wpi but significantly smaller in p38α^+/-^ mice than in WT mice at each time point. These results suggest that the functional and histopathological recovery after SCI may be enhanced or accelerated in p38α^+/-^ mice compared with WT mice. Remyelination of regenerated axons are likely to be one of key mechanisms involved in the spontaneous recovery of motor function after SCI ([@B22]). As shown in **Figure [2B](#F2){ref-type="fig"}**, Luxol Fast Blue (LFB)-stained area on transverse section of the SC of the two genotypes was significantly smaller in the SCI group compared with the sham-operated group. And, the LFB-positive ratio was significantly larger in p38α^+/-^ mice than in WT mice at 4 wpi (**Figure [2C](#F2){ref-type="fig"}**). At 2 wpi, the LFB-positive staining in the white matter of SC of the two genotypes was much weaker than the case at 4 wpi (data not shown), suggesting that axonal remyelination may occur at least over a time period ranging from 2 to 4 wpi. Likewise, axons labeled by an anterograde tracer, Texas Red-BDA were more frequently observed in caudal part of the SC of p38α^+/-^ mice than of WT mice at 4 wpi, a semi-quantitative analysis of which showed a significant difference between the both genotypes (**Figure [2D](#F2){ref-type="fig"}**). The labeled frequency in rostral part of the SC was equally high between the two genotypes because axonal degeneration predominantly occurred in caudal part of the SC, and axons are intact in 5 mm rostral to the lesion epicenter of SC after the hemi-section injury. These results suggest that axonal regeneration and remyelination after SCI may be enhanced or accelerated in p38α^+/-^ mice compared with WT mice. To elucidate the mechanism underlying the improved signs of SCI in p38α^+/-^ mice, we focused on various pathological events at 1 and 2 wpi in which the difference in improvement of spontaneous locomotor ability after SCI between p38α^+/-^ mice and WT mice was recognized and then manifested.

![**Histopathological changes after SCI. (A)** Typical profiles of HE-stained sagittal SC sections from WT and p38α^+/-^ mice at 1, 2, and 4 weeks post-injury. **(B)** Transverse SC sections from WT and p38α^+/-^ mice at 4 weeks post-injury (1 mm caudal of the lesion epicenter) or with sham-operation (the corresponding site) were stained by a KB method. LFB-staining area was surrounded with the dotted lines. **(C)** Quantitative evaluation of **(A)** and **(B)**. Left column, SCI-associated leukocyte infiltration into SC of WT (open bars) and p38α^+/-^ (closed bars) mice. Right column, ratio of LFB-staining area to right hemi-SC area in WT (open bars) and p38α^+/-^ (closed bars) mice. Data are shown as mean ± SEM (*n* = 5). ^∗^*P* \< 0.05 (ANOVA followed by Tukey's test), ^\#^*P* \< 0.05 (Student's *t*-test for unpaired values). **(D)** Representative images of Texas Red-BDA-labeled axons in the white matter of SC of WT and p38α^+/-^ mice at 4 weeks post-injury. In the SCI group, sagittal sections of SC at 5 mm rostral and 5 mm caudal to the lesion epicenter were observed. In the sham-operated group, SC segment corresponding to the lesion epicenter (T9) of the SCI group was observed. Texas-Red BDA staining area caudal to the lesion epicenter was expressed as the percentage of the whole field. Data are shown as mean ± SEM (*n* = 5). ^∗^*P* \< 0.05 (Student's *t*-test for unpaired values).](fphar-08-00072-g002){#F2}

Characterization of Inflammatory Response and Evaluation of Oligodendrocyte Apoptosis between p38α^+/-^ and WT Mice at 1 wpi
----------------------------------------------------------------------------------------------------------------------------

A significant importance of leukocytes-mediated inflammatory reaction is well known in the development of SCI. In particular, T lymphocytes invade the lesion site, concomitantly to macrophages and secrete cytokines in the lesion epicenter, which results in axonal damage and motor neuron apoptosis after SCI ([@B6]; [@B4]). Moreover, a previous report demonstrated that the expression of p38 was enhanced in resident and infiltrating immune cell after SCI ([@B44]). Thus, we elucidated cell populations of leukocytes and T lymphocytes detected as CD45^+^ and CD3^+^, respectively, in the lesion. As shown in **Figures [3A,B](#F3){ref-type="fig"}**, CD45^+^ and CD3^+^ cells were observed in the lesion of the two genotypes at 1 wpi, each number of which was significantly lower in p38α^+/-^ mice than WT mice. In general, neutrophils are a major cell population of CD45^+^ cells and contribute to both the progression of damage and the tissue repair after SCI ([@B29]). However, Ly6G^+^ neutrophils were hardly detected in the lesion at 1 wpi (data not shown), which was supported by a previous report that neutrophil recruitment showed fast kinetics reaching a peak at 1 day and immediately declining to the baseline within several days ([@B11]). Considering cell types of leukocytes in the inflammation of SCI, thus, CD45^+^CD3^-^ cells in the lesion at 1 wpi may be mainly monocytes/macrophages. At the same time point, we also investigated the comprehensive analysis of SCI-induced change in expression of inflammation-related proteins in the SC. As shown in **Figure [3C](#F3){ref-type="fig"}**, we found 15 molecules \[C-X-C motif chemokine 12 (CXCL12); Eotaxin-2; Galectin-3; insulin-like growth factor 2 (IGF-II), IL-2 receptor γ (IL-2Rγ); IL-9; IL-9 receptor (IL-9R); IL-12/p70; Kremen-1; macrophage inflammatory protein 1α (MIP-1α); MIP-2; matrix metalloproteinase 9 (MMP-9); Osteoactivin; tissue inhibitors of metalloproteinase 4 (TIMP-4); Toll-like receptor 2 (TLR2)\] showing a clear difference in their expression between WT and p38α^+/-^ mice. The lower expression of MIP-1α, MIP-2, and MMP-9 was corroborated as less leucocyte infiltration in the injured SC of p38α^+/-^ mice ([@B17]). In particular, MMP-9 has been thought to open the blood-SC barrier and promote migration of leukocytes into the lesion, which may directly influence the severity of SCI ([@B30]). It has been also reported that MMP-9 and CXCL12 function synergistically to facilitate migration of blood-borne monocyte ([@B52]), although CXCL12 has been regarded as one of key chemoattractants that regulates migration of homeostatic stem and progenitor cells in animal models of CNS injury and promote axonal sprouting ([@B17]). Therefore, it can be speculated that the decreased expression of both MMP-9 and CXCL12 in p38α^+/-^ mice may lead to the less infiltrating leucocytes ([@B44]). Furthermore, MIP-1α and CXCL12 can recruit T lymphocytes into the injured site ([@B35]; [@B17]). Thus, their decreased expression may be closely related to the reduction of T cell infiltration in p38α^+/-^ mice. On the other hand, Galectin-3 and TLR2 have been reported to have protective effects on SCI through regulating inflammatory response ([@B19]; [@B43]; [@B14]; [@B26]). Among the 15 molecules, only SCI-induced Galectin-3 was higher in p38α^+/-^ mice compared with WT mice, suggesting that the increase of Galectin-3 may also contribute to the less infiltrating leucocytes in p38α^+/-^ mice. Further study is needed to elucidate whether functional inhibition of each molecule by its neutralizing antibody affects the severity of SCI. However, the decrease in concomitant infiltration of monocytes/macrophages and T lymphocytes associated with the changes in expression of several cytokines/chemokines may contribute to the less development of SCI in p38α^+/-^ mice.

![**Inflammatory profiles 1 week after SCI. (A)** Typical profile of CD3^+^CD45^+^ cells in the lesion epicenter of the two genotypes at 1 week post-injury. Asterisks indicate double-positive cells. **(B)** Quantitative evaluation of **(A)**. CD3^+^ cells and CD45^+^ cells in the injured site within 500 μm rostrocaudal of the lesion epicenter increased in both WT (open bars) and p38α^+/-^ (closed bars) mice at 1 week post-injury, the number of which was significantly lower in p38α^+/-^ mice than WT mice. Data are shown as mean ± SEM (*n* = 5). ^∗^*P* \< 0.05 (ANOVA followed by Tukey's test). **(C)** SCI-induced changes in expression of cytokines in the SC between WT and p38α^+/-^ mice. Collected SC protein sample from five mice of each group (WT-sham, WT-SCI, p38α^+/-^-sham or p38α^+/-^-SCI) were subjected to protein array for 308 molecules. Three independent experiments were conducted (15 mice in each group). Using a densitometer, each signal was normalized to the positive internal controls included in the array membrane (P1-a), and expressed as induction ratio of the sham-operated value. Among 61 molecules (≥2, induction ratio in WT group), 15 molecules showed a significant difference in their induction ratio between the two genotypes. Data are shown as mean ± SEM (*n* = 3). The difference between WT (open squares) and p38α^+/-^ (filled squares) mice was statistically significant (^∗^*P* \< 0.05) as determined by Student's *t*-test for unpaired values.](fphar-08-00072-g003){#F3}

In CNS, p38 mainly localizes in myelin sheath but not in axon ([@B23]). It has been reported that inhibition of p38 prevents myelin structure destruction associated with oligodendrocytic apoptosis and ameliorates neurological deficits after SCI ([@B15]). It has also been reported that apoptosis of oligodendrocyte would occur about 1 week after SCI and cause demyelination and axonal disturbance ([@B21]; [@B10]). As a reliable strategy, colocalized cells of CNPase and cleaved caspase-3 are regarded as oligodendrocytes under programmed cell death in human SCI ([@B12]). Then, we evaluated a cell population of cleaved caspase-3^+^CNPase^+^ cells in the white matter of the lesion. As shown in **Figure [4](#F4){ref-type="fig"}**, cleaved caspase-3^+^CNPase^+^ cells were typically observed in the SCI group of the two genotypes at 1 wpi (A), the number of which was significantly lower in p38α^+/-^ mice than WT mice (B). On the other hand, Nissle^+^ neuronal cells decreased in the gray matter of SC around the lesion epicenter in the two genotypes at 1 wpi, which was significantly moderate in p38α^+/-^ mice than WT mice (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}). These results indicated that p38α^+/-^ mice showed resistance to cell death of oligodendrocytes and neurons at 1 wpi. Hence, the inflammatory responses and cell death of oligodendrocytes and neurons after SCI were reduced by a single copy disruption of *p38*α *gene*. Next, we elucidated a role of p38α in the tissue regeneration process after SCI.

![**Changes in numbers of apoptotic oligodendrocytes in the white matter 1 week after SCI. (A)** Typical profile of cleaved caspase-3^+^CNPase^+^ cells in the white matter at the caudal boarder of the lesion of the two genotypes at 1 week post-injury. Asterisks indicate double-positive cells. **(B)** Cleaved caspase-3^+^CNPase^+^ cells in the injured site within 500 μm rostrocaudal of the lesion epicenter increased in both WT (open bars) and p38α^+/-^ (closed bars) mice at 1 week post-injury, the number of which was significantly lower in p38α^+/-^ mice than WT mice. Data are shown as mean ± SEM (*n* = 4--5). ^∗^*P* \< 0.05 (ANOVA followed by Tukey's test).](fphar-08-00072-g004){#F4}

Astrocytic Scar Formation and Increase in Oligodendrocyte Precursor Cells after SCI between p38α^+/-^ and WT Mice
-----------------------------------------------------------------------------------------------------------------

In a great numbers of studies, glial scar by reactive astrocytes has been regarded as physical barriers to successful axon regeneration ([@B41]). In contrast, recent studies have provided the possibility that reactive astrogliosis have beneficial effects in axonal regeneration via forming the astrocyte bridge, a scaffold for axonal growth ([@B1]; [@B25]). On the other hand, activated microglias and macrophages markedly infiltrate into the lesion of CNS injury, the spread degree of which is closely associated with substantial tissue repair and functional restoration ([@B37]). Thus, the cellular formation of GFAP^+^ astrocytes and Iba1^+^ microglias/macrophages between p38α^+/-^ mice and WT mice was examined at 2 wpi. As shown in **Figure [5](#F5){ref-type="fig"}**, astrocytic scar formation was observed in the epicenter of the two genotypes, which was more massive in WT mice (B and C) than p38α^+/-^ mice (F and G). Likewise, a larger numbers of reactive astrocytes with hypertrophied somas and long processes were observed in WT mice (D) than p38α^+/-^ mice (H). These phenomena were supported by a previous study that astrogliosis after CNS damage might be attenuated in astrocyte-specific p38α-knockout mice ([@B39]). On the other hand, Iba1^+^ microglias/macrophages were accumulated more compactly between rostrocaudal GFAP^+^ reactive astrocytes in p38α^+/-^ mice than WT mice (**Figures [5B,C,F,G](#F5){ref-type="fig"}**). Likewise, the distance between rostrocaudal glial scars was shorter in p38α^+/-^ mice than WT mice (**Figures [5A,E](#F5){ref-type="fig"}**), indicating that contraction of lesion area was enhanced in p38α^+/-^ mice compared with WT mice. It has been reported that the Stat3-upregulated migratory activity of reactive astrocytes to seclude inflammatory cells enhances contraction of lesion area and functional restoration after SCI ([@B32]). Moreover, a loss of function of p38α in astrocyte negatively affects its cellular migration activity ([@B39]). Thus, more typical compaction of microglias/macrophages associated with smaller wound area in p38α^+/-^ mice compared with WT mice is of interest. Probably, at least the less infiltration of inflammatory cells related to expression of proinflammatory cytokines (**Figure [3](#F3){ref-type="fig"}**) may positively affect the wound healing process in p38α^+/-^ mice even though astrogliosis-forming activity is moderate compared with WT mice. In addition, it was also provided the possibility that the contribution of NSCs to wound healing/tissue regeneration process after SCI might be potentiated in p38α^+/-^ mice.

![**Astrocytic scar formation and neuroinflammation-associated cells at 2 weeks post-injury. (A,E)** Representative images of sagittal sections showing GFAP^+^ reactive astrocytes and Iba1^+^ cells at 2 weeks post-injury. **(B,C,F,G)** Higher magnification images from the boxed area, b, c, f and g in **(A)** and **(E)**. Iba1^+^ cells were compacted to the lesion center between rostrocaudal reactive astrocytes, which was more apparent in the SC of p38α^+/-^ mice than that of WT mice. **(D,H)** Higher magnification images of GFAP^+^ reactive astrocytes from the boxed area, d (in **A**) and h (in **E**). GFAP^+^ reactive astrocytes at 1 mm caudal to the lesion epicenter decreased in p38α^+/-^ mice compared with WT mice.](fphar-08-00072-g005){#F5}

Multipotent NSCs are defined as cells that can self-renew and differentiate into the three neuronal lineages, neuron, astrocyte, and oligodendrocyte ([@B13]). In the SC, NSCs known as ependymal cells in the central canal proliferate rapidly after SCI and differentiate into more than half the astrocytes in the glial scar and a small amount of oligodendrocytes ([@B2]). Likewise, *in vitro*, NSCs derived from adult WT mice easily and exclusively differentiate into astrocyte with repeating cell passages without appropriate neurotrophic factors ([@B40]; [@B7]). Hence, the low differentiation capacity of adult NSC for neural and oligodendrocytic lineages can limit the recovery from SCI. We previously reported that NSCs in the adult hippocampus of p38α^+/-^ mice have much higher self-renewal activity and neural differentiation capacity compared with those of WT mice ([@B51]). These findings tempted us to think that activity of progenitor cells for oligodendrocyte and neuron might be upregulated in p38α^+/-^ mice under the tissue regeneration process after SCI. To elucidate this point, we observed cell populations of oligodendrocyte precursor cells (OPCs) and neural progenitor cells in the lesion epicenter of SC at 2 wpi. As we expected, the number of NG2^+^ OPCs in the white matter of the lesion increased in the two genotypes at 2 wpi, which was significantly higher in p38α^+/-^ mice than in WT mice (**Figure [6](#F6){ref-type="fig"}**). NG2^+^ OPCs into the injured SC can enhance remyelination of spared axons and improve functional recovery after SCI ([@B49]). Thus, in conjunction with the results shown in **Figures [2B,C](#F2){ref-type="fig"}**, the increase in OPCs in p38α^+/-^ mice after SCI may contribute to the efficiency of remyelination under the tissue regeneration process. We also determined that NG2^+^ cells were more accumulated along the laceration/epicenter in p38α^+/-^ mice compared with WT mice (data not shown). This accumulation was very similar to typical histopathological findings in CNS damages including SCI ([@B47]). NG2 is a member of chondroitin sulphate proteoglycans (CSPGs) generally known to be repulsive to growing axons. However, NG2 also called CSPG4 has been recently recognized as a promoting molecule for axonal growth and regeneration ([@B50]). In fact, it has been demonstrated that astrocytes forming a bridge across a scar after SCI highly express CSPG4/NG2 ([@B1]). Likewise, NG2^+^ OPCs provide an adhesive substrate for axonal growth by forming a bridge after SCI ([@B8]). Although we could not detected the astrocytic bridge between rostrocaudal glial scars in the two genotypes (**Figure [5](#F5){ref-type="fig"}**), the fact that accumulation of NG2^+^ OPCs along the laceration/epicenter was more apparent in p38α^+/-^ mice compared with WT mice might affect the efficiency of axonal regeneration between the two genotypes. In addition to the upregulation of OPC recruitment in p38α^+/-^ mice, an increase in DCX^+^ neural progenitor cells in the gray matter of the lesion was bigger in p38α^+/-^ mice than in WT mice at 2 wpi. Some of the DCX^+^ neural progenitor cells also expressed Nestin and were observed in area proximal to the lesion epicenter in the two genotypes. Notably, DCX^+^Nestin^+^ cells were also detected within the epicenter in case of p38α^+/-^ mice but not WT mice (Supplementary Figure [2](#SM2){ref-type="supplementary-material"}). DCX^+^Nestin^+^ cells have been identified as resident multipotent NSCs in the SC meninges and at least contribute to parenchymal reaction following SCI ([@B9]). Although it is still unclear whether the DCX^+^Nestin^+^ cells recruited into the lesion contribute to neural regeneration, the finding that recruitment of neuroblasts and resident NSCs to the lesion was upregulated in p38α^+/-^ mice may affect the subsequent tissue regeneration in concert with the enhanced recruitment of OPCs.

![**Change in numbers of NG2^+^ cells in the white matter at 2 weeks after SCI. (A)** Typical profile of NG2^+^ cells in the lesion epicenter of the two genotypes at 2 weeks post-injury. **(B)** NG2^+^ cells in the injured site within 500 μm rostrocaudal of the lesion epicenter in the SCI group were increased in the two genotypes at 1 week post-injury, the number of which was significantly higher in p38α^+/-^ mice (closed bars) than WT mice (open bars). Data are shown as mean ± SEM (*n* = 4--5). ^∗^*P* \< 0.05 (ANOVA followed by Tukey's test).](fphar-08-00072-g006){#F6}

Together, a single copy disruption of *p38*α *gene* affected the tissue degeneration and regeneration processes and improved the functional recovery from SCI. However, the question arose as to whether the SCI-augmented p38 activation was inhibited in the SC of p38α^+/-^ mice. Although SCI did not affect each expression level of p38α in the two genotypes, the SCI-augmented p38 activation was less in p38α^+/-^ mice compared with WT mice (Supplementary Figure [3](#SM3){ref-type="supplementary-material"}). Therefore, we finally evaluated the effect of a p38 inhibitor on the functional recovery from SCI.

A p38 Inhibitor Improved Locomotor Recovery after SCI
-----------------------------------------------------

Unlike the previous studies on the association between SCI and a p38 inhibitor ([@B15]; [@B44]), we used SB239063 as a p38 inhibitor that is an orally active and transferable across the blood-cerebrospinal fluid barrier. In the preliminary study, we confirmed that an oral administration of SB239063 (10 mg/kg body weight) could efficiently inhibit the SCI-induced p38α activity (Supplementary Figure [4](#SM4){ref-type="supplementary-material"}). Then, based on a previous report that the strong activation of p38 MAPK in the injured SC increases from 12 h to 3 days ([@B42]), we orally administrated SB239063 to WT mice (10 mg/kg per day) at 1, 2, and 3 dpi. As we expected, the BMS score was significantly higher in the SB239063-treated group compared with the vehicle group over a time period ranging from 6 to 28 dpi (**Figure [7](#F7){ref-type="fig"}**), indicating that a pharmacological inhibition of p38α also improved the recovery of hindlimb behavior after SCI.

![**Effect of SB239063 on hindlimb locomotor behavior after SCI.** WT mice with SCI received oral administration of vehicles (*filled squares*) and SB239063 (10 mg/kg per day, *filled circles*) at 1, 2, and 3 dpi. Functional recovery from SCI was better in mice with SB239063 treatment than those with vehicle administration. Data are shown as mean ± SEM (*n* = 6). ^∗^*P* \< 0.05, a significant difference between the two groups by Mann--Whitney *U* test for unpaired values at each time point.](fphar-08-00072-g007){#F7}

Our present result that SB239063 is effective on the functional recovery after lateral hemisection of the SC can be supported by the previous study employing a mild contusion model of SCI by [@B15]. On the other hand, another study demonstrated that a p38α inhibitor failed to improve functional outcome after SCI with moderate contusion ([@B44]). Currently, the discrepancy in efficacy of a p38α inhibitor for SCI between them is difficult to explain. Regardless of the type of SCI model, however, the intensity of SC damage may influence the beneficial effect of a p38α inhibitor. In addition, the route and schedule of administration with a p38α inhibitor also affect its efficacy. As a next step, to investigate whether our protocol of SB239063 administration is effective in a moderate contusion model of SCI is needed.

Conclusion
==========

A single copy disruption of *p38*α *gene* inhibited the tissue degenerative events such as leukocytic infiltration, expression of cytokines/chemokines and apoptosis of oligodendrocyte and neuron and enhanced the tissue regenerative events such as compaction of microglias/macrophages, recruitment of OPCs and NSC and axonal regrowth and remyelination, which resulted in a better functional recovery from SCI. We also demonstrated that a pharmacological inhibition of p38α could recapitulate the better functional recovery from SCI observed in p38α^+/-^ mice. Our present study clearly suggests that p38α contributes to the pathogenesis of SCI and propose that an orally active p38α inhibitor, SB239063 may have therapeutic benefits for the treatment of SCI.
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